APL-MONTELUKAST TABS montelukast (as sodium) 5mg chewable tablet blister pack

Active ingredient:

montelukast sodium, Quantity: 5.19 mg

Available from:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

montelukast sodium

Pharmaceutical form:

Tablet, chewable

Composition:

Excipient Ingredients: mannitol; microcrystalline cellulose; hyprolose; croscarmellose sodium; iron oxide red; aspartame; magnesium stearate; Flavour

Administration route:

Oral

Units in package:

28, 14

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Prophylaxis and treatment of chronic asthma in adults and children 2 years of age and older. Symptomatic treatment of seasonal allergic rhinitis.

Product summary:

Visual Identification: Pink coloured, mottled, round, biconvex, uncoated tablets debossed with X on one side and 53 on other side; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2013-01-07